Biology subjects

Killen, A. C.

Publications and source records attributed to Killen, A. C..

2 recordsLinked to original sources

bioRxiv2024

Injured endocardium obtains characteristics of haemogenic endothelium during adult zebrafish heart regeneration

Reactivation of embryonic developmental pathways during regeneration aims to restore tissue architecture and functionality. We previously reported that following cryoinjury, a heterogeneous population of Runx1-expressing endocardial cells differentially upregulates genes associate with scarring and myofibroblast identity. Further analysis of our published RNAseq data alongside 5 publicly available datasets now identifies additional heterogeneity in the Runx1-positive injured endocardium. Here, we show that the endocardium also reactivates a dormant endocardial-to-haematopoietic transition (EHT) mechanism. Runx1-expressing endocardial cells upregulate genes associated with haemogenesis and morphologically display features of EHT. Live imaging shows cells budding off the endocardium and lineage analysis identifies overlap with leukocyte markers. Ablation of runx1 function further shifts differentiation of the endocardium towards the EHT fate. The identification of transient runx1-expressing cells transitioning towards myofibroblast or haemogenic endocardium identities demonstrates the complexity of the zebrafish endocardial injury response and highlights the role of Runx1 in regulating cell fate decisions in the endocardium.

developmental biology↗

bioRxiv2019

Runx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration

Runx1 is a transcription factor that plays a key role in determining the proliferative and differential state of multiple cell-types, during both development and adulthood. Here, we report how runx1 is specifically upregulated at the injury site during zebrafish heart regeneration, but unexpectedly, absence of runx1 results in enhanced regeneration. Using single cell sequencing, we found that the wild-type injury site consists of Runx1-positive endocardial cells and thrombocytes that induce expression of smooth muscle and collagen genes without differentiating into myofibroblasts. Both these populations are absent in runx1 mutants, resulting in a less collagenous and fibrinous scar. The reduction in fibrin in the mutant is further explained by reduced myofibroblast formation and by upregulation of components of the fibrin degradation pathway, including plasminogen receptor Annexin 2A as well as downregulation of plasminogen activator inhibitor serpine1 in myocardium and endocardium, resulting in increased levels of Plasminogen. In addition, we find enhanced myocardial proliferation as well as increased myocardial survival in the mutant. Our findings suggest that Runx1 controls the regenerative response of multiple cardiac cell-types and that targeting Runx1 is a novel therapeutic strategy to induce endogenous heart repair.

developmental biology↗